Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 60% decrease from the number of companies inspected in the previous month, when five companies received five inspections.
The companies inspected were involved in either the Biologics or Food and Cosmetics sectors.
There was one company in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Gulf Coast Regional Blood Center | Biologics | 07/17/2024 | No Action Indicated (NAI) |
Winfull Corporation | Food and Cosmetics | 07/26/2024 | Official Action Indicated (OAI) |